Ivermectin and outcomes from Covid-19 pneumonia: A systematic review and meta-analysis of randomized clinical trial studies

DOI record: { "DOI": "10.1002/rmv.2265", "ISSN": [ "1052-9276", "1099-1654" ], "URL": "http://dx.doi.org/10.1002/rmv.2265", "abstract": "<jats:title>Summary</jats:title><jats:p>Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity. This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes. We systematically searched the PubMed, Europe PMC and ClinicalTrials.gov database using specific keywords related to our aims until 10th May 2021. All published randomized clinical trial studies on Covid‐19 and ivermectin were retrieved. The quality of the study was assessed using Jadad scale assessment tool for clinical trial studies. Statistical analysis was done using Review Manager 5.4 software. A total of 19 studies with 2768 Covid‐19 patients were included in this meta‐analysis. This meta‐analysis showed that ivermectin was associated with reduction in severity of Covid‐19 (RR 0.43 [95% CI 0.23–0.81], <jats:italic>p</jats:italic> = 0.008), reduction of mortality (RR 0.31 [95% CI 0.15–0.62], <jats:italic>p</jats:italic> = 0.001), higher negative RT‐PCR test results rate (RR 1.23 [95% CI 1.01–1.51], <jats:italic>p</jats:italic> = 0.04), shorter time to negative RT‐PCR test results (mean difference [MD] −3.29 [95% CI −5.69, −0.89], <jats:italic>p</jats:italic> = 0.007), higher symptoms alleviations rate (RR 1.23 [95% CI 1.03−1.46], <jats:italic>p</jats:italic> = 0.02), shorter time to symptoms alleviations (MD −0.68 [95% CI −1.07, −0.29], <jats:italic>p</jats:italic> = 0.0007) and shorter time to hospital discharge (MD −2.66 [95% CI −4.49, −0.82], <jats:italic>p</jats:italic> = 0.004). Our study suggests that ivermectin may offer beneficial effects towards Covid‐19 outcomes. More randomized clinical trial studies are still needed to confirm the results of our study.</jats:p>", "alternative-id": [ "10.1002/rmv.2265" ], "assertion": [ { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Received", "name": "received", "order": 0, "value": "2021-05-16" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Accepted", "name": "accepted", "order": 1, "value": "2021-06-02" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 2, "value": "2021-06-06" } ], "author": [ { "ORCID": "http://orcid.org/0000-0002-1748-9776", "affiliation": [ { "name": "Faculty of Medicine Pelita Harapan University Tangerang Indonesia" } ], "authenticated-orcid": false, "family": "Hariyanto", "given": "Timotius Ivan", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0001-5246-7946", "affiliation": [ { "name": "Faculty of Medicine Pelita Harapan University Tangerang Indonesia" } ], "authenticated-orcid": false, "family": "Halim", "given": "Devina Adella", "sequence": "additional" }, { "affiliation": [ { "name": "Faculty of Medicine Pelita Harapan University Tangerang Indonesia" } ], "family": "Rosalind", "given": "Jane", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-9853-0752", "affiliation": [ { "name": "Faculty of Medicine Pelita Harapan University Tangerang Indonesia" } ], "authenticated-orcid": false, "family": "Gunawan", "given": "Catherine", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-5219-9029", "affiliation": [ { "name": "Department of Internal Medicine Faculty of Medicine Pelita Harapan University Tangerang Indonesia" } ], "authenticated-orcid": false, "family": "Kurniawan", "given": "Andree", "sequence": "additional" } ], "container-title": "Reviews in Medical Virology", "container-title-short": "Reviews in Medical Virology", "content-domain": { "crossmark-restriction": true, "domain": [ "onlinelibrary.wiley.com" ] }, "created": { "date-parts": [ [ 2021, 6, 7 ] ], "date-time": "2021-06-07T12:31:09Z", "timestamp": 1623069069000 }, "deposited": { "date-parts": [ [ 2023, 8, 27 ] ], "date-time": "2023-08-27T13:39:42Z", "timestamp": 1693143582000 }, "indexed": { "date-parts": [ [ 2024, 3, 25 ] ], "date-time": "2024-03-25T18:44:29Z", "timestamp": 1711392269062 }, "is-referenced-by-count": 17, "issue": "2", "issued": { "date-parts": [ [ 2021, 6, 6 ] ] }, "journal-issue": { "issue": "2", "published-print": { "date-parts": [ [ 2022, 3 ] ] } }, "language": "en", "license": [ { "URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 6, 6 ] ], "date-time": "2021-06-06T00:00:00Z", "timestamp": 1622937600000 } } ], "link": [ { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2265", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/rmv.2265", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2265", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "311", "original-title": [], "prefix": "10.1002", "published": { "date-parts": [ [ 2021, 6, 6 ] ] }, "published-online": { "date-parts": [ [ 2021, 6, 6 ] ] }, "published-print": { "date-parts": [ [ 2022, 3 ] ] }, "publisher": "Wiley", "reference": [ { "key": "e_1_2_11_2_1", "unstructured": "World Health Organization. Coronavirus disease (COVID‐19): situation report.2020.https://www.who.int/publications/m/item/weekly‐epidemiological‐update‐‐‐22‐december‐2020Accessed December 24." }, { "article-title": "Anosmia/Hyposmia is a good predictor of coronavirus disease 2019 (COVID‐19) infection: a meta‐analysis", "author": "Hariyanto TI", "first-page": "e170", "journal-title": "Int Arch Otorhinolaryngol", "key": "e_1_2_11_3_1", "volume": "25", "year": "2020" }, { "DOI": "10.1016/j.ijcha.2020.100557", "doi-asserted-by": "publisher", "key": "e_1_2_11_4_1" }, { "DOI": "10.1016/j.tmaid.2020.101623", "doi-asserted-by": "publisher", "key": "e_1_2_11_5_1" }, { "DOI": "10.1016/j.jiph.2020.03.019", "doi-asserted-by": "publisher", "key": "e_1_2_11_6_1" }, { "DOI": "10.1016/j.transci.2020.102926", "doi-asserted-by": "publisher", "key": "e_1_2_11_7_1" }, { "DOI": "10.1016/j.dsx.2020.07.044", "doi-asserted-by": "publisher", "key": "e_1_2_11_8_1" }, { "DOI": "10.1016/j.parkreldis.2021.04.019", "doi-asserted-by": "publisher", "key": "e_1_2_11_9_1" }, { "DOI": "10.4102/sajhivmed.v22i1.1220", "doi-asserted-by": "publisher", "key": "e_1_2_11_10_1" }, { "article-title": "Dementia is associated with severe coronavirus disease 2019 (COVID‐19) infection", "author": "Hariyanto TI", "first-page": "374", "issue": "3", "journal-title": "Am J Med Sci", "key": "e_1_2_11_11_1", "volume": "361", "year": "2020" }, { "DOI": "10.1016/j.dld.2020.10.001", "doi-asserted-by": "publisher", "key": "e_1_2_11_12_1" }, { "article-title": "Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID‐19) in diabetic patients: a systematic review, meta‐analysis, and meta‐regression", "author": "Hariyanto TI", "first-page": "1", "journal-title": "J Diabetes Metab Disord", "key": "e_1_2_11_13_1", "year": "2021" }, { "DOI": "10.1016/j.ajem.2020.12.076", "doi-asserted-by": "publisher", "key": "e_1_2_11_14_1" }, { "DOI": "10.12688/f1000research.26186.1", "doi-asserted-by": "publisher", "key": "e_1_2_11_15_1" }, { "article-title": "Efficacy and safety of remdesivir in hospitalized Covid‐19 patients: systematic review and meta‐analysis including network meta‐analysis", "author": "Elsawah HK", "first-page": "e2187", "journal-title": "Rev Med Virol", "key": "e_1_2_11_16_1", "year": "2020" }, { "article-title": "Efficacy and safety of tocilizumab for coronavirus disease 2019 (Covid‐19) patients: a systematic review and meta‐analysis", "author": "Hariyanto TI", "first-page": "265", "issue": "5", "journal-title": "Drug Res (Stuttg)", "key": "e_1_2_11_17_1", "volume": "71", "year": "2020" }, { "DOI": "10.1111/1440-1681.13488", "doi-asserted-by": "publisher", "key": "e_1_2_11_18_1" }, { "DOI": "10.1002/rmv.2134", "doi-asserted-by": "publisher", "key": "e_1_2_11_19_1" }, { "DOI": "10.1208/s12248-007-9000-9", "doi-asserted-by": "publisher", "key": "e_1_2_11_20_1" }, { "DOI": "10.1038/srep23138", "doi-asserted-by": "publisher", "key": "e_1_2_11_21_1" }, { "DOI": "10.1016/j.antiviral.2013.06.002", "doi-asserted-by": "publisher", "key": "e_1_2_11_22_1" }, { "DOI": "10.1042/BJ20120150", "doi-asserted-by": "publisher", "key": "e_1_2_11_23_1" }, { "DOI": "10.1016/j.antiviral.2020.104787", "doi-asserted-by": "publisher", "key": "e_1_2_11_24_1" }, { "DOI": "10.1016/0197-2456(95)00134-4", "doi-asserted-by": "publisher", "key": "e_1_2_11_25_1" }, { "DOI": "10.1371/journal.pone.0166141", "doi-asserted-by": "publisher", "key": "e_1_2_11_26_1" }, { "DOI": "10.1186/1471-2288-14-135", "doi-asserted-by": "publisher", "key": "e_1_2_11_27_1" }, { "DOI": "10.1016/j.ijid.2020.11.191", "doi-asserted-by": "publisher", "key": "e_1_2_11_28_1" }, { "DOI": "10.1093/qjmed/hcab035", "doi-asserted-by": "publisher", "key": "e_1_2_11_29_1" }, { "article-title": "Efficacy of ivermectin in COVID‐19 patients with mild to moderate disease", "author": "Bukhari KHS", "journal-title": "medRxiv", "key": "e_1_2_11_30_1", "year": "2021" }, { "DOI": "10.18483/ijSci.2378", "doi-asserted-by": "publisher", "key": "e_1_2_11_31_1" }, { "article-title": "A randomized trial of ivermectin‐doxycycline and hydroxychloroquine‐azithromycin therapy on COVID19 patients", "author": "Chowdhury ATMM", "first-page": "63", "issue": "1", "journal-title": "EJMO", "key": "e_1_2_11_32_1", "volume": "5", "year": "2021" }, { "article-title": "Efficacy and safety of ivermectin for treatment and prophylaxis of COVID‐19 pandemic", "author": "Elgazzar A", "journal-title": "Research Square", "key": "e_1_2_11_33_1", "year": "2020" }, { "article-title": "Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID‐19. A randomized controlled trial", "author": "Gonzalez JLB", "journal-title": "medRxiv", "key": "e_1_2_11_34_1", "year": "2021" }, { "article-title": "Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID‐19 patients in Baghdad, Iraq", "author": "Hashim HA", "journal-title": "medRxiv", "key": "e_1_2_11_35_1", "year": "2020" }, { "article-title": "Ivermectin as adjuvant to hydroxychloroquine in patients resistant to standard treatment for sars‐cov‐2: results of an open‐label randomized clinical study", "author": "Kishoria N", "first-page": "50", "issue": "8", "journal-title": "Paripex ‐ Indian J Res", "key": "e_1_2_11_36_1", "volume": "9", "year": "2020" }, { "DOI": "10.1001/jama.2021.3071", "doi-asserted-by": "publisher", "key": "e_1_2_11_37_1" }, { "article-title": "Clinical trial of ivermectin plus doxycycline for the treatment of confirmed covid‐19 infection", "author": "Mahmud R", "journal-title": "ClinicalTrials.gov", "key": "e_1_2_11_38_1", "year": "2020" }, { "article-title": "Ivermectin in mild and moderate COVID‐19 (RIVETCOV): a randomized, placebo‐controlled trial", "author": "Mohan A", "journal-title": "Research Square", "key": "e_1_2_11_39_1", "year": "2021" }, { "article-title": "Ivermectin as an adjunct treatment for hospitalized adult COVID‐19 patients: a randomized multi‐center clinical trial", "author": "Niaee MS", "journal-title": "Research Square", "key": "e_1_2_11_40_1", "year": "2020" }, { "DOI": "10.1186/s12879-021-06104-9", "doi-asserted-by": "publisher", "key": "e_1_2_11_41_1" }, { "DOI": "10.3329/imcjms.v14i2.52826", "doi-asserted-by": "publisher", "key": "e_1_2_11_42_1" }, { "DOI": "10.1016/j.toxrep.2021.03.003", "doi-asserted-by": "publisher", "key": "e_1_2_11_43_1" }, { "article-title": "Ivermectin as a potential treatment for mild to moderate COVID‐19—a double blind randomized placebo‐controlled trial", "author": "Ravikitri R", "journal-title": "medRxiv", "key": "e_1_2_11_44_1", "year": "2021" }, { "DOI": "10.1016/j.clinthera.2021.04.007", "doi-asserted-by": "publisher", "key": "e_1_2_11_45_1" }, { "key": "e_1_2_11_46_1", "unstructured": "ShoumanW NafaeRM RagabM et al. Use of Ivermectin as a prophylactic option in asymptomatic family close contacts for patients with COVID‐19. ClinicalTrials.gov. 2020. NCT04422561." }, { "DOI": "10.1016/S0895-4356(99)00161-4", "doi-asserted-by": "publisher", "key": "e_1_2_11_47_1" }, { "DOI": "10.1002/sim.1461", "doi-asserted-by": "publisher", "key": "e_1_2_11_48_1" }, { "DOI": "10.1055/a-1185-8913", "doi-asserted-by": "publisher", "key": "e_1_2_11_49_1" }, { "DOI": "10.1016/j.eclinm.2020.100720", "doi-asserted-by": "publisher", "key": "e_1_2_11_50_1" }, { "DOI": "10.1111/eci.13429", "doi-asserted-by": "publisher", "key": "e_1_2_11_51_1" }, { "DOI": "10.1007/s00011-008-8007-8", "doi-asserted-by": "publisher", "key": "e_1_2_11_52_1" }, { "DOI": "10.1007/s00011-011-0307-8", "doi-asserted-by": "publisher", "key": "e_1_2_11_53_1" } ], "reference-count": 52, "references-count": 52, "relation": {}, "resource": { "primary": { "URL": "https://onlinelibrary.wiley.com/doi/10.1002/rmv.2265" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1002/crossmark_policy", "volume": "32" }